Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

CMOs and their care teams need to take steps to avoid preventable complication risks among Parkinson's disease patients in ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

By Dr. Chinta Sidharthan Sensor data from wearable devices analyzed over five years reveals walking and posture differences ...

Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

Aug. 19, 2024 — Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Aug. 19, 2024 — Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems ...

An Oxford study has shown how data could be used to predict the risk of falls in people with Parkinson’s disease.

An Oxford study has shown how data could be used to predict the risk of falls in people with Parkinson’s disease.